Vascularized Bone Grafts for Tissue Engineering

用于组织工程的血管化骨移植物

基本信息

项目摘要

DESCRIPTION (provided by applicant): The candidate, Dr. Edward Botchwey, is experienced in orthopaedic biomaterials and tissue engineering. His long term career goal is to establish an independent research laboratory to pursue his interests in the development of experimental and computational methods to study the role of angiogenesis and microvascular remodeling in bone tissue engineering. His intermediate term objective is to work together with mentor Dr. Thomas Skalak, chair of biomedical engineering at the University of Virginia, to leverage the tremendous resources available at UVA to achieve this goal. This proposal outlines a career development plan to design and build new enabling technologies capable of co-cultivating osteoblastic cells and vascular endothelial cells within tissue engineered scaffolds, and varying the geometric arrangement of cells so that optimization of both bone remodeling and neo-vascularization can be explored. In vivo experimental assessment and novel computational modeling approaches will be developed to identify the geometries of combined cell distribution that are most conducive to bone healing and vascular remodeling. The specific objectives of the proposal are 1) to quantify the effects of perfusion flow velocity and internal pore network geometry on rMSC proliferation, gene expression, and mineralized deposition within 3-D microsphere based scaffolds in a customized perfusion. 2) to develop new experimental methods to co-culture rat microvascular endothelial cells (rVECs) within mineralized rMSC constructs formed in Aim1. Specifically, rVECs will be cultivated according to two predetermined geometric configurations, (a) uniformly dispersed network within the scaffolds, and (b) externally laminated layer around the scaffolds. 3) to combine experimental and computational methods to determine whether the geometric distribution of vascular endothelial cells within mineralized bone tissue engineered scaffolds developed in Aim 2 enhance microvascular network remodeling and ectopic bone formation in a customized rat window chamber model in viv.
描述(由申请人提供):候选人Edward Botchwey博士在骨科生物材料和组织工程中经验丰富。他的长期职业目标是建立一个独立的研究实验室,以追求他对开发实验和计算方法的兴趣,以研究血管生成和微血管重塑在骨组织工程中的作用。 他的中级目标是与弗吉尼亚大学生物医学工程主席的导师托马斯·斯卡拉克(Thomas Skalak)博士一起工作,以利用UVA可用的巨大资源来实现这一目标。该提案概述了一项职业发展计划,以设计和建立能够在组织工程脚手架内共培养成骨细胞和血管内皮细胞的新的促成技术,并可以探索细胞的几何布置,从而优化骨重塑和新骨骼血管生成。将开发体内实验评估和新颖的计算建模方法,以确定最有利于骨骼愈合和血管重塑的组合细胞分布的几何形状。 该提案的特定目标是1)量化灌注流速度和内部孔网络几何形状对RMSC增殖,基因表达和矿化沉积的影响。 2)在AIM1中形成的矿化RMSC构建体中开发新的实验方法,以共培养大鼠微血管内皮细胞(RVEC)。具体而言,RVEC将根据两种预定的几何构型进行培养,(a)脚手架内均匀分散的网络,以及(b)脚手架周围的外部层压层。 3)结合实验和计算方法,以确定在AIM 2中开发的矿化骨组织工程支架中血管内皮细胞的几何分布是否增强了VIV中定制的大鼠窗室模型中的微血管网络重塑和异位骨形成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Edward A. Botchwey的其他基金

T32 CTEng (Cellular and Tissue Engineering) Training Program
T32 CTEng(细胞和组织工程)培训计划
  • 批准号:
    10641891
    10641891
  • 财政年份:
    2022
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
T32 CTEng (Cellular and Tissue Engineering) Training Program
T32 CTEng(细胞和组织工程)培训计划
  • 批准号:
    10420388
    10420388
  • 财政年份:
    2022
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Artery biomechanics and vascular damage in sickle cell disease
镰状细胞病的动脉生物力学和血管损伤
  • 批准号:
    10390381
    10390381
  • 财政年份:
    2021
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Artery biomechanics and vascular damage in sickle cell disease
镰状细胞病的动脉生物力学和血管损伤
  • 批准号:
    10606485
    10606485
  • 财政年份:
    2021
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptides
使用光触发体内粘附肽激活的再生免疫疗法
  • 批准号:
    10252435
    10252435
  • 财政年份:
    2020
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction
用于骨骼肌重建的免疫调节纳米纤维
  • 批准号:
    9565183
    9565183
  • 财政年份:
    2017
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
2015 Biomaterials & Tissue Engineering Gordon Research Conference and Gordon Research Seminar
2015年生物材料
  • 批准号:
    8986494
    8986494
  • 财政年份:
    2015
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Therapeutic S1P Drug Targets for Cranial Bone Repair
颅骨修复的治疗性 S1P 药物靶点
  • 批准号:
    8069853
    8069853
  • 财政年份:
    2009
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Therapeutic S1P Drug Targets for Cranial Bone Repair
颅骨修复的治疗性 S1P 药物靶点
  • 批准号:
    8543695
    8543695
  • 财政年份:
    2009
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering
用于治疗性动脉生成和组织工程的磷脂生长因子
  • 批准号:
    8895064
    8895064
  • 财政年份:
    2009
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:

相似海外基金

Optimizing Revascularization by EC Transplantation
通过 EC 移植优化血运重建
  • 批准号:
    7135566
    7135566
  • 财政年份:
    2006
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Cell Response to 3D Engineered Gradients of FGF-2
细胞对 FGF-2 3D 工程梯度的反应
  • 批准号:
    7060419
    7060419
  • 财政年份:
    2005
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Cell Response to 3D Engineered Gradients of FGF-2
细胞对 FGF-2 3D 工程梯度的反应
  • 批准号:
    6851399
    6851399
  • 财政年份:
    2005
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Structural Graft Healing: Angiogenesis and Osteogenesis
结构性移植物愈合:血管生成和成骨
  • 批准号:
    6811882
    6811882
  • 财政年份:
    2004
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别:
Pro-angiogenic Collagen Implants
促血管生成胶原蛋白植入物
  • 批准号:
    6833595
    6833595
  • 财政年份:
    2004
  • 资助金额:
    $ 12.55万
    $ 12.55万
  • 项目类别: